Sunshine Biopharma Inc. (NASDAQ:SBFM)
| Market Cap | $4.74M-99.2% |
| Revenue (ttm) | n/a-5.2% |
| Net Income | n/a-3.0% |
| EPS | n/a+90.8% |
| Shares Out | 2.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,935 |
| Open | $2.34 |
| Previous Close | $2.35 |
| Day's Range | $2.23 - $2.35 |
| 52-Week Range | $2.23 - $464.00 |
| Beta | 1.35 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
About SBFM
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.
$SBFM stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SBFM holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SBFM's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SBFM Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SBFM patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SBFM from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from SBFM’s recent data — informational, not investment advice
